Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation on the Effectiveness and Safety of AI-based Coronary CT Angiographic Analysis Software (RuiXin-CoronaryAI) for Diagnosis of Coronary Artery Stenosis

NCT05320185 is registered in ClinicalTrials.gov with Shenzhen Raysight Intelligent Medical Technology Co., Ltd. as lead sponsor.

NCT NCT05320185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05320185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation on the Effectiveness and Safety of AI-based Coronary CT Angiographic Analysis Software (RuiXin-CoronaryAI) for Diagnosis of Coronary Artery Stenosis
Lead sponsor
Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
July 28, 2021
Completion date
December 30, 2022
Enrollment
615 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence, coronary artery disease, coronary artery stenosis, ct angiography